Atlas Trials

Seyma Acik

1 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Seyma Acik

RecordFirmDate
Gremlin-1 and Wagner Classification: Potential Biomarker for Amputation in Diabetic Foot Patients (NCT06753604)Seyma Acik2019-12-20

Track Seyma Acik automatically

Every clearance here is in the API, with alerts when new ones post.